Skip to content
Disclosery

Syncona Portfolio Ltd

Follow

13F filer, CIK 1725042, St Peter Port, Guernsey, United Kingdom

Syncona Portfolio Ltd reported $25,705,701 across 2 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001193125-26-222811

Period
2026-03-31
Reported value
$25.7M
Holdings
2
Top 10 weight
100%
New
0
Sold out
0

Part of the filer group Syncona Portfolio Ltd

How groups are built

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001193125-26-222811, largest first. % of portfolio is the value over $25,705,701, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 18,554,624 shares; 2024Q4: 16,640,720 shares; 2025Q1: 16,640,720 shares; 2025Q2: 16,640,720 shares; 2025Q3: 16,640,720 shares; 2025Q4: 16,640,720 shares; 2026Q1: 16,640,720 shares 16,640,720$23M89.34%0Timeline
IPSCCENTURY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,213,056 shares; 2024Q4: 1,213,056 shares; 2025Q1: 1,213,056 shares; 2025Q2: 1,213,056 shares; 2025Q3: 1,213,056 shares; 2025Q4: 1,213,056 shares; 2026Q1: 1,213,056 shares 1,213,056$2.74M10.66%0Timeline

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-26-222811 base2026-05-14acceptance time not in the bulk data set